SFP
EBS icon

Santa Fe Partners’s Emergent Biosolutions EBS Stock Holding History

Santa Fe Partners’s Portfolio EBS Stock Details EBS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-8,799
Closed -$250K – 479
2015
Q3 		$250K Buy
+8,799
New +$290K 0.03% 430

Other funds holding EBS

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

Santa Fe Partners's EBS Position: Q4 2015 in Review

Santa Fe Partners sold out of Emergent Biosolutions (EBS) in Q4 2015, closing a stake of 8,799 shares — an estimated $250K sold.

Santa Fe Partners first reported a position in EBS in Q3 2015 and held it in 1 quarter. The position peaked at $250K in Q3 2015. 205 funds tracked by Wall St. Rank hold EBS as of Q4 2015.

  • Santa Fe Partners reported no remaining Emergent Biosolutions position as of Q4 2015 after selling out during the quarter.
  • Santa Fe Partners sold 8,799 Emergent Biosolutions shares in Q4 2015, an estimated $250K.
  • Santa Fe Partners first reported a position in Emergent Biosolutions in Q3 2015 and held it in 1 quarter.
  • Santa Fe Partners's Emergent Biosolutions position peaked at $250K in Q3 2015.
  • 205 funds tracked by Wall St. Rank held Emergent Biosolutions as of Q4 2015.

Based on Santa Fe Partners's 13F filing for Q4 2015, filed 12 Feb 2016.